UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Amendment No. 2
Under the Securities Exchange Act of 1934
China Cord Blood Corporation
(Name of Issuer)
Ordinary Shares, $0.0001 par value
(Title of Class of Securities)
G21107100
(CUSIP Number)
December 31, 2013
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. G21107100
1. Names of Reporting Persons.
Atlantis Investment Management (Hong Kong) Ltd
2. Check the Appropriate Box if a Member Of a Group
[ ] (a)
[X] (b)
3. SEC Use Only
4. Citizenship or Place of Organization
Hong Kong
5. Sole Voting Power: 0
Number of Shares
6. Shared Voting Power: 2,281,709
Beneficially Owned by
7. Sole Dispositive Power: 0
Each Reporting Person With:
8. Shared Dispositive Power: 2,281,709
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,281,709
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
11. Percent of Class Represented by Amount in Row (9)
3.13%*
12. Type of Reporting Person
IA
* Based upon 73,003,248 ordinary shares outstanding, as reported by China Cord
Blood Corporation on its Form 6-K/A as filed with the Securities and Exchange
Commission on December 12, 2013.
|
CUSIP No. G21107100
1. Names of Reporting Persons.
Atlantis Capital Holdings Ltd
2. Check the Appropriate Box if a Member Of a Group
[ ] (a)
[X] (b)
3. SEC Use Only
4. Citizenship or Place of Organization
Hong Kong
5. Sole Voting Power: 0
Number of Shares
6. Shared Voting Power: 2,281,709
Beneficially Owned by
7. Sole Dispositive Power: 0
Each Reporting Person With:
8. Shared Dispositive Power: 2,281,709
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,281,709
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
11. Percent of Class Represented by Amount in Row (9)
3.13%*
12. Type of Reporting Person
HC
* Based upon 73,003,248 ordinary shares outstanding, as reported by China Cord
Blood Corporation on its Form 6-K/A as filed with the Securities and Exchange
Commission on December 12, 2013.
|
CUSIP No. G21107100
1. Names of Reporting Persons.
Yang Liu
2. Check the Appropriate Box if a Member Of a Group
[ ] (a)
[X] (b)
3. SEC Use Only
4. Citizenship or Place of Organization
Hong Kong
5. Sole Voting Power: 0
Number of Shares
6. Shared Voting Power: 2,281,709
Beneficially Owned by
7. Sole Dispositive Power: 0
Each Reporting Person With:
8. Shared Dispositive Power: 2,281,709
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,281,709
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
11. Percent of Class Represented by Amount in Row (9)
3.13%*
12. Type of Reporting Person
HC
* Based upon 73,003,248 ordinary shares outstanding, as reported by China Cord
Blood Corporation on its Form 6-K/A as filed with the Securities and Exchange
Commission on December 12, 2013.
|
Item 1. (a) Name of Issuer: China Cord Blood Corporation
(b) Address of Issuer's Principal Executive Offices:
48th Floor, Bank of China Tower
1 Garden Road
Central, Hong Kong S.A.R.
Item 2. (a) Name of Person Filing:
Atlantis Investment Management (Hong Kong) Limited
(b) Address of Principal Business Office, or, if None, Residence:
Room 3501, The Centrium
60 Wyndham Street
Central, Hong Kong
Hong Kong
(c) Citizenship:
Hong Kong
(d) Title of Class of Securities:
Ordinary Shares, par value $0.0001 per share
(e) CUSIP No.: G21107100
Item 3. If This Statement is Filed Pursuant to Rules 13d-1(b), or 13d-2(b) or
(c), Check Whether the Person Filing is a:
(a) [ ] Broker or dealer registered under Section 15 of the Act.
(b) [ ] Bank as defined in Section 3(a)(6) of the Act.
(c) [ ] Insurance company as defined in Section 3(a)(19) of the Act.
(d) [ ] Investment company registered under Section 8 of the
Investment Company Act of 1940.
(e) [X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)
(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940;
(j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Item 4. Ownership
Please see Items 5 - 9 and 11 on each cover sheet for each
Reporting Person
Item 5. Ownership of Five Percent or Less of a Class
X If this statement is being filed to report the fact that, as of the
date hereof the Reporting Persons have ceased to be the beneficial
owners of more than five percent of the class of securities, check
the following [x].
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company
or Control Person
Not Applicable
Item 8. Identification and Classification of Members of the Group
Not Applicable
Item 9. Notice of Dissolution of Group
Not Applicable
Item 10. Certifications
The following certification shall be included if the statement is filed
pursuant to Rule 13d-1(b):
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired and are held in the ordinary
course of business and were not acquired and are not held for the purpose of
or with the effect of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: FEBRUARY 12, 2014
Atlantis Investment Management (Hong Kong) Ltd
By: /s/ Philip Thomas
--------------------------
Name: Philip Thomas
Title: Chief Compliance Officer
|
Atlantis Capital Holdings Ltd
By: /s/ Irene Fung
--------------------------
Name: Irene Fung
Title: Director
|
Yang Liu
By: /s/ Yang Liu
--------------------------
|
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Jul 2023 to Jul 2024
